Invention Grant
- Patent Title: Solvent cast film sustained release latanoprost implant
- Patent Title (中): 溶剂流延膜缓释拉坦前列素植入物
-
Application No.: US13457785Application Date: 2012-04-27
-
Publication No.: US08715713B2Publication Date: 2014-05-06
- Inventor: Alazar N. Ghebremeskel , Lon T. Spada
- Applicant: Alazar N. Ghebremeskel , Lon T. Spada
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jennifer C. Cheng; Joel B. German; Debra D. Condino
- Main IPC: A61F2/00
- IPC: A61F2/00 ; A61K9/00 ; A61F9/00 ; A61K31/5575 ; A61K47/34
Abstract:
The present invention provides a sustained release latanoprost implant in the form of a thin film comprising latanoprost incorporated in a biodegradable polymer matrix. Preferably, said implant is an intraocular implant comprising a thin film comprising latanoprost incorporated in a biodegradable polymer matrix wherein said implant is configured as a disc or a rolled film that can be inserted into the eye and unrolls to provide a film having a high surface area to volume ratio.
Public/Granted literature
- US20120276184A1 SOLVENT CAST FILM SUSTAINED RELEASE LATANOPROST IMPLANT Public/Granted day:2012-11-01
Information query
IPC分类:
